Biology of Blood and Marrow Transplantation
Volume 14, Issue 1 , Pages 110-115 , January 2008

Clinical Evaluation of Oral Chronic Graft-Versus-Host Disease

  • Nathaniel S. Treister

      Affiliations

    • Brigham and Women's Hospital, Boston, Massachusetts
    • Corresponding Author InformationCorrespondence and reprint requests: Nathaniel S. Treister, DMD, DMSc, Division of Oral and Maxillofacial Surgery, Oral Medicine and Dentistry, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115.
  • ,
  • Earl Francis Cook Jr.

      Affiliations

    • Brigham and Women's Hospital, Boston, Massachusetts
  • ,
  • Joseph Antin

      Affiliations

    • Dana-Farber Cancer Institute, Boston, Massachusetts
  • ,
  • Stephanie J. Lee

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington
  • ,
  • Robert Soiffer

      Affiliations

    • Dana-Farber Cancer Institute, Boston, Massachusetts
  • ,
  • Sook-Bin Woo

      Affiliations

    • Brigham and Women's Hospital, Boston, Massachusetts

Received 12 October 2006 ,Accepted 9 June 2007.

References 

  1. Lee SJ. New approaches for preventing and treating chronic graft-versus-host disease. Blood. 2005;105:4200–4206
  2. Woo SB, Lee SJ, Schubert MM. Graft-vs.-host disease. Crit Rev Oral Biol Med. 1997;8:201–216
  3. Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2003;9:215–233
  4. Bhushan V, Collins RH. Chronic graft-vs-host disease. JAMA. 2003;290:2599–2603
  5. Socie G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med. 1999;341:14–21
  6. Lee SJ, Klein JP, Barrett AJ, et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood. 2002;100:406–414
  7. Curtis RE, Metayer C, Rizzo JD, et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood. 2005;105:3802–3811
  8. Flowers ME, Parker PM, Johnston LJ, et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood. 2002;100:415–419
  9. Schubert MM, Sullivan KM, Morton TH, et al. Oral manifestations of chronic graft-v-host disease. Arch Intern Med. 1984;144:1591–1595
  10. Mattsson T, Arvidson K, Heimdahl A, Ljungman P, Dahllof G, Ringden O. Alterations in taste acuity associated with allogeneic bone marrow transplantation. J Oral Pathol Med. 1992;21:33–37
  11. Rodu B, Gockerman JP. Oral manifestations of the chronic graft-v-host reaction. JAMA. 1983;249:504–507
  12. Barrett AP, Bilous AM. Oral patterns of acute and chronic graft-v-host disease. Arch Dermatol. 1984;120:1461–1465
  13. Berkowitz RJ, Strandjord S, Jones P, et al. Stomatologic complications of bone marrow transplantation in a pediatric population. Pediatr Dent. 1987;9:105–110
  14. Dahllof G, Heimdahl A, Modeer T, Twetman S, Bolme P, Ringden O. Oral mucous membrane lesions in children treated with bone marrow transplantation. Scand J Dent Res. 1989;97:268–277
  15. Hiroki A, Nakamura S, Shinohara M, Oka M. Significance of oral examination in chronic graft-versus-host disease. J Oral Pathol Med. 1994;23:209–215
  16. Nakamura S, Hiroki A, Shinohara M, et al. Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;82:556–563
  17. Treister NS, Woo SB, O'Holleran EW, Lehmann LE, Parsons SK, Guinan EC. Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11:721–731
  18. Piboonniyom SO, Treister N, Pitiphat W, Woo SB. Scoring system for monitoring oral lichenoid lesions: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:696–703
  19. Liang K, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:12–22
  20. Busca A, Locatelli F, Vai S, Dall'Omo AM, Gargiulo A, Falda M. Clinical grading of oral chronic graft-versus-host disease in 104 consecutive adult patients. Haematologica. 2005;90:567–569
  21. Pavletic SZ, Martin P, Lee SJ, et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant. 2006;12:252–266
  22. Pavletic SZ, Lee SJ, Socie G, Vogelsang G. Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials. Bone Marrow Transplant. 2006;38:645–651
  23. Shlomchik WD, Lee SJ, Couriel D, Pavletic SZ. Transplantation's greatest challenges: advances in chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2007;13:2–10
  24. Nicolatou-Galitis O, Kitra V, Van Vliet-Constantinidou C, et al. The oral manifestations of chronic graft-versus-host disease (cGVHD) in paediatric allogeneic bone marrow transplant recipients. J Oral Pathol Med. 2001;30:148–153
  25. Campana F, Sibaud V, Chauvel A, Boiron JM, Taieb A, Fricain JC. Recurrent superficial mucoceles associated with lichenoid disorders. J Oral Maxillofac Surg. 2006;64:1830–1833
  26. Koc S, Leisenring W, Flowers ME, et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood. 2002;100:48–51
  27. Stewart BL, Storer B, Storek J, et al. Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood. 2004;104:3501–3506

PII: S1083-8791(07)00509-5

doi: 10.1016/j.bbmt.2007.06.017

Biology of Blood and Marrow Transplantation
Volume 14, Issue 1 , Pages 110-115 , January 2008